MORR Capital  ·  Equity capital

Equity is the most expensive capital you will raise.

It should be the last rung you reach for and it is usually the first. Before running a raise we test whether you need one — and if you do, we take it to the investors whose mandate actually fits rather than to everyone.

Capabilities

What the mandate covers.

The instrument follows the situation. Most of the value in a raise is created by choosing the right rung of the capital structure before anyone is approached.

Growth equity
Minority capital for businesses with a proven model and a use of funds that survives scrutiny. Priced on evidence rather than on the number the raise needs to clear.
Minority recapitalizations
Liquidity for shareholders while keeping control: the structure most founders want and most do not know to ask for.
Structured and preferred equity
Instruments between debt and common, used where the valuation gap is real and neither side should have to be wrong about it.
Late-stage private placements
Rounds for businesses with institutional-grade reporting and a path that no longer depends on a single outcome.
Co-investment
Single-asset vehicles and co-investment alongside sponsors, structured for parties who want the exposure without the fund.
Sponsor equity
Control capital from financial buyers, run as a process so terms are set by competition rather than by the first mover.
Doctrine

Four things that govern the work.

Not house preference. These are the conclusions the evidence supports, and they decide what happens in the weeks that actually move the number.

The right rung first

Most raises are a debt question asked in equity language. Working capital, an acquisition, or an equipment purchase usually has a cheaper answer, and we test that before running anything.

The wrong door wastes the raise

Investors have mandates, and a mandate mismatch is not a persuasion problem. Six wrong conversations cost more credibility than they cost time.

Valuation is built, not argued

From peers, cost of capital, and scenarios — with the ranges on one page and what each price implies for the next round stated plainly.

Terms outlive valuation

Liquidation preference, participation, board composition, and consent rights decide the outcome far more often than headline valuation does.

Process

How the mandate runs.

Every engagement runs the same nine phases. Below is how they compress for this mandate.

01

The right-rung test

Whether equity is the answer, settled before anything goes to market.

Deliverables
  • Use of funds tested against cheaper structures
  • Dilution modelled against the debt alternative
  • Readiness assessed across reporting and governance
  • An honest recommendation, including not raising
02

Packaging

Materials built for the investor who will rebuild your model.

Deliverables
  • Equity story with evidence behind each claim
  • Driver-level assumptions defensible in diligence
  • Data room structured before the first request
  • Valuation range with the implications stated
03

Process

Tiering, wall-crossing, and a real comparison.

Deliverables
  • Investor universe tiered by mandate fit
  • Outreach sequence protecting the process
  • Term sheets normalized and compared
  • Negotiation on terms, not only on price
04

Close

Diligence, documentation, and a cap table you can live with.

Deliverables
  • Confirmatory diligence coordinated
  • Shareholder agreement negotiated alongside counsel
  • Governance and consent rights settled
  • Post-close reporting obligations mapped
Engagement references available upon request.
Important information

MORR Capital is a division of MORR Group. Nothing on this page is an offer to sell or a solicitation of an offer to buy any security, nor is it investment, legal, tax, or accounting advice. No communication through this page creates an advisory or fiduciary relationship.

MORR Group is not a registered broker-dealer, investment adviser, or municipal advisor, and is not a member of FINRA or SIPC. Engagements are accepted only where permitted by applicable law, including under the exemption for M&A brokers at Section 15(b)(13) of the Securities Exchange Act of 1934 and applicable state law. Where a mandate would require registration we do not accept it, or we engage a registered broker-dealer to conduct the regulated activity.

Any direct investments described are made with MORR’s own capital and are not offered to outside investors. Past performance of any business, transaction, or investment is not indicative of future results.

Descriptions of process, phases, and workstreams are general information about how engagements are typically run. They are not tailored to any recipient’s circumstances and should not be relied upon as the basis for any decision. No representation is made that any transaction, financing, or mandate will be completed, completed on any particular timeline, or completed on any particular terms. Any statements about future events or expected outcomes are forward-looking and subject to risks and uncertainties outside our control.

Content on this page is provided as of the date published, may not be current, and is subject to change without notice. Third-party names, marks, and logos are the property of their respective owners, and their appearance does not imply any endorsement, partnership, or affiliation. Nothing here creates any obligation on MORR Group to provide services.